Ilevro (nepafenac) — ALCON LABS.

Post-op ocular inflammation
Postoperative ocular pain
0.3 % eye drops,suspension
Instill 1 drop to the operated eye by ophthalmic route once daily beginning 1 day prior to surgery, continued on day of surgery and throughthe first 2 weeks of post-operative period. Instill 1 additional drop30-120 minutes before surgery.

Post-op ocular inflammation
Dosage Type: Suspension, drops(final dosage form)(ml)
Instill 1 drop to the operated eye by ophthalmic route once daily beginning 1 day prior to surgery, continued on day of surgery and throughthe first 2 weeks of post-operative period. Instill 1 additional drop30-120 minutes before surgery.

Postoperative ocular pain
Instill 1 drop to the operated eye by ophthalmic route once daily beginning 1 day prior to surgery, continued on day of surgery and throughthe first 2 weeks of post-operative period. Instill 1 additional drop30-120 minutes before surgery.
Severe Warnings
Keratitis
Ocular bleeding
Contraindicated
Corneal epithelial degeneration
Corneal erosion
Corneal ulcer
Perforation of cornea
Moderate Warnings
Decreased corneal sensitivity
Diabetes mellitus
Impaired wound healing
Increased risk of bleeding
Rheumatoid arthritis
Tear film insufficiency
Less Frequent
Severe
Chemosis
Conjunctival hyperemia
Corneal edema
Ocular pain
Sinusitis
Vitreous detachment

Less Severe
Dry eye
Eye tearing
Eyelash crusting
Headache disorder
Hypertension
Nausea
Ocular irritation
Ocular itching
Photophobia
Vomiting
More Frequent
Severe
Corneal opacity
Ocular hypertension
Reduced visual acuity

Less Severe
Foreign body sensation of eye
Sticky sensation of eye
Rare / Very Rare
Severe
Corneal erosion
Corneal ulcer
Impaired wound healing

Less Severe
Corneal dystrophy
More information
Contraindicated
None

Severe Precaution
None

Management or Monitoring Precaution
Nepafenac
1 Day – 10 Years
Safety and efficacy not established age < 10 years.
Nepafenac
Severity Level: C
Additional Notes: Syst absorp unknown;not rec 3rd trimest,premature closure duct arterriosus risk

More information
Contraindicated
None

Precaution Exists
Nepafenac
GeneralExcretion PotentialEffect on InfantNotes
Evaluate use carefullyUnknownNot known; no or inclusive dataDrug excreted in rat studies, insufficient human data available

No Known Risk
None
More information
No precaution information has been provided for this patient type.
Post-op ocular inflammation
379.99Ill-defined eye disorders not elsewhere classified
Postoperative ocular pain
338Pain not elsewhere classified
338.1Acute pain
338.18Other acute postoperative pain
338.19Other acute pain
379.91Pain in or around eye
0-9 A-Z
338 Pain not elsewhere classified
338.1 Acute pain
338.18 Other acute postoperative pain
338.19 Other acute pain
379.91 Pain in or around eye
379.99 Ill-defined eye disorders not elsewhere classified

Data included with permission and copyrighted by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgement of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. Diagnosis codes are provided for reference only. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatement.